Showing 1431-1440 of 9281 results for "".
6 Tools That Can Benefit Every Dermatology Provider
https://practicaldermatology.com/topics/practice-management/6-tools-that-can-benefit-every-dermatology-provider/23283/Whether you’ve never heard of it or simply forgot about it, each of these tools can improve patient care in the clinic.A Closer Look at Skyrizi
https://practicaldermatology.com/columns/clinical-focus-1/a-closer-look-at-skyrizi/23016/The newest IL-23 blocker for psoriasis may prove to be a blockbuster, according to analysts.Harnessing the Power of Humor for Psoriasis
https://practicaldermatology.com/topics/psoriasis/harnessing-the-power-of-humor-for-psoriasis/23007/Humor can create positive changes in our thoughts, feelings, behaviors, and biochemistry and can also influence how patients cope.Lyme Disease Update
https://practicaldermatology.com/topics/general-topics/lyme-disease-update/20604/Exploring current thinking about Lyme Disease diagnosis and treatment.Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.We Care: Ten Tips on Building Patient Rapport
https://practicaldermatology.com/topics/practice-management/we-care-ten-tips-on-building-patient-rapport/22908/Relationships should be nurtured by anyone with whom patients have contact during their visit.An Update on At-Home UVB Phototherapy
https://practicaldermatology.com/topics/general-topics/an-update-on-at-home-uvb-phototherapy/21786/At-home options increase accessibility to phototherapy, which is effective and generally safe for psoriasis management.Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://practicaldermatology.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
https://practicaldermatology.com/programs/cme/clinical-data-prompting-guideline-updates-for-subcutaneous-icis-in-melanoma/36329/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
https://practicaldermatology.com/programs/cme/clinical-implications-of-neoadjuvant-therapy-guideline-updates-in-resectable-melanoma/36323/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.